Cargando…
Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development
The development of copper-drug complexes (CDCs) is hindered due to their very poor aqueous solubility. Diethyldithiocarbamate (DDC) is the primary metabolite of disulfiram, an approved drug for alcoholism that is being repurposed for cancer. The anticancer activity of DDC is dependent on complexatio...
Autores principales: | Wehbe, Mohamed, Anantha, Malathi, Backstrom, Ian, Leung, Ada, Chen, Kent, Malhotra, Armaan, Edwards, Katarina, Bally, Marcel B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824478/ https://www.ncbi.nlm.nih.gov/pubmed/27055237 http://dx.doi.org/10.1371/journal.pone.0153416 |
Ejemplares similares
-
Development of a copper-clioquinol formulation suitable for intravenous use
por: Wehbe, Moe, et al.
Publicado: (2017) -
Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use
por: Chen, Kent T. J., et al.
Publicado: (2019) -
Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent
por: Wehbe, Mohamed, et al.
Publicado: (2017) -
Concomitant Chemoradiation Therapy with Gold Nanoparticles and Platinum Drugs Co-Encapsulated in Liposomes
por: Charest, Gabriel, et al.
Publicado: (2020) -
Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status
por: Wehbe, Mohamed, et al.
Publicado: (2017)